🇺🇸 FDA
Pipeline program

18F-PEG6-IPQA

2009-0832

Phase 1 small_molecule completed

Quick answer

18F-PEG6-IPQA for Lung Cancer is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Lung Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials